EUVIMEDEUVIMED entdecken
Crossref

HPV Genomic Status in Early Cervical Cancer and Its Prognosis Association

Imane Doghman iD, Rosa Montero-Macías, Victor Malassigné iD, Julien Puech, Sandrine Imbeaud, Marie-Aude Le Frère-Belda, Pascal Rigolet, Mélanie Boulhic, Ivana Stankovic, Martina Aida Angeles, Eliane Mery, Anne-Sophie Bats und 4 weitere

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70720 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Imane Doghman und 15 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche des Cordeliers, Inserm, Université Paris Cité, Functional Genomics of Solid Tumors Laboratory, Paris, France. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Papillomavirus Infections, Genome, Viral, Papillomaviridae. Die Arbeit nennt 44 Literaturangaben. Gefördert von: This study received a financial support from ARCAGY-GINECO "Translational research grant 2019" and Fondation ARC. This study also received financial support fr….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Identify specific Human Papilloma Virus (HPV) genomic status by HPV capture technique coupled with next‐generation sequencing (NGS) in patients with early cervical cancer (ECC) regarding 2018 FIGO stages and correlate these statuses with prognosis. HPV sequencing by Capture technique coupled with NGS was performed on 34 tumors samples of ECC patients without histologically sentinel lymph node (SLN) metastasis in a retrospective study. NGS data were analyzed in our in‐house VIROCAPT2 pipeline to determine precise HPV genomic status such as the complete sequence of HPV genome, its integration or not in host genome and correlate this viral identity card with patient's clinical prognosis. As expected, HPV16 remains the most common genotype (60%, n = 21/35) in ECC. HPV integration was identified in 40% ( n = 14/35) of samples. We found that in ECC, integration events were related with HPV genotype ( p = 0.0005). Among the 40% of integrated HPV, 8 were found integrated within human genes, including 2 into oncogenes. Finally, women with integrated HPV had a poorest outcome with a strong correlation between progression‐free survival and HPV integration ( p = 0.0035) and interestingly, the 2 HPV integrated into oncogenes were observed in patients who died from cancer. HPV genomic status seems to be a key prognostic factor in early stage cervical cancer, with HPV integration strongly linked to poor outcomes. Larger studies are needed to confirm the clinical relevance of HPV ID card for risk stratification and treatment decisions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsPapillomavirus InfectionsGenome, ViralPapillomaviridaeHumansFemaleRetrospective StudiesMiddle AgedPrognosisAdultVirus IntegrationHigh-Throughput Nucleotide SequencingAgedGenotypeDNA, Viral

Stichwörter der Autor:innen

genital tract, pathogenesishuman papillomavirus, virus classificationoncogenesissurvival analysis, biostatistics and bioinformatics

Substanzen

DNA, Viral

Autor:innen und Institutionen

  • Centre de Recherche des Cordeliers, Inserm, Université Paris Cité, Functional Genomics of Solid Tumors Laboratory, Paris, France.
  • Faculté de Santé, UFR de Médecine, Université Paris Cité, Paris, France.
  • Obstetrics and Gynecology Department, Hospital Center of Poissy Saint-Germain-en-Laye, Poissy, France.
  • Complutense University of Madrid, Madrid, Spain.
  • Virology Laboratory, Hôpital Européen Georges-Pompidou, APHP Centre - Université Paris Cité, Paris, France.
  • Pathology Department, Hôpital Européen Georges-Pompidou, APHP Centre - Université Paris Cité, Paris, France.

ORCID-Profile: Imane Doghman, Victor Malassigné, Hélène Péré

Förderung

  • This study received a financial support from ARCAGY-GINECO "Translational research grant 2019" and Fondation ARC. This study also received financial support fr…

Zitieren

APA

Doghman, I., Montero-Macías, R., Malassigné, V., Puech, J., Imbeaud, S., Le Frère-Belda, M. A., Rigolet, P., Boulhic, M., Stankovic, I., Angeles, M. A., Mery, E., Bats, A. S., Mathevet, P., Lécuru, F., Veyer, D., & Péré, H. (2025). HPV Genomic Status in Early Cervical Cancer and Its Prognosis Association. Journal of Medical Virology. https://doi.org/10.1002/jmv.70720

Vancouver

Doghman I, Montero-Macías R, Malassigné V, Puech J, Imbeaud S, Le Frère-Belda MA, et al. HPV Genomic Status in Early Cervical Cancer and Its Prognosis Association. Journal of Medical Virology. 2025. doi:10.1002/jmv.70720

BibTeX
@article{Doghman2025,
  author = {Doghman, Imane and Montero-Macías, Rosa and Malassigné, Victor and Puech, Julien and Imbeaud, Sandrine and Le Frère-Belda, Marie-Aude and Rigolet, Pascal and Boulhic, Mélanie and Stankovic, Ivana and Angeles, Martina Aida and Mery, Eliane and Bats, Anne-Sophie and Mathevet, Patrice and Lécuru, Fabrice and Veyer, David and Péré, Hélène},
  title = {HPV Genomic Status in Early Cervical Cancer and Its Prognosis Association},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70720}
}
Kostenlos starten →